Alphatec Inc.
Rating
Updated: Aug 25, 2026Key Statistics
Market Data
Valuation (TTM)
Valuation (NTM)
Cash Flow
Margins
Growth (CAGR)
Returns
Financial Health
Dividends
Profile
Alphatec Holdings, Inc. is a medical technology firm dedicated to engineering and advancing solutions for the surgical management of spinal conditions. Its product array includes the Alpha InformatiX ...
Latest News
8 days ago · zacks.com
Alphatec (ATEC) Moves 19.7% Higher: Will This Strength Last?Alphatec (ATEC) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
2 months ago · seekingalpha.com
Alphatec Holdings, Inc. (ATEC) Q2 2026 Earnings Call TranscriptAlphatec Holdings, Inc. (ATEC) Q2 2026 Earnings Call Transcript
2 months ago · zacks.com
Alphatec (ATEC) Q2 Earnings Lag EstimatesAlphatec (ATEC) came out with quarterly earnings of $0.07 per share, missing the Zacks Consensus Estimate of $0.09 per share. This compares to earnings of $0.02 per share a year ago.
2 months ago · marketbeat.com
Alphatec Q2 Earnings Call HighlightsAlphatec NASDAQ: ATEC reported second-quarter 2026 revenue of $214 million, up 15% from a year earlier, as growth in surgical procedures and surgeon adoption supported higher profitability and positive free cash flow.
2 months ago · businesswire.com
ATEC Announces Participation in Upcoming Investor ConferencesCARLSBAD, Calif.--(BUSINESS WIRE)--Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that management will participate in the following investor conference(s): Management will host one-on-one investor meetings at the 11th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference on Monday, August 10, 2026. Management will present to investors at the 19th Annual Piper Sandler MedTech and Dia.
2 months ago · businesswire.com
ATEC to Report Second Quarter 2026 Financial Results on August 4, 2026CARLSBAD, Calif.--(BUSINESS WIRE)--Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that it will report second quarter 2026 financial results on August 4, 2026, after the market close. The Company will host a live webcast that day at 1:30 p.m. PT / 4:30 p.m. ET.WebcastTo access the live webcast, please use this link or visit the Investor Relations Events & Presentations section of ATEC's cor.
3 months ago · globenewswire.com
Alphatec Holdings Investor Alert: Johnson Fistel Reviews Potential Claims for ShareholdersSAN DIEGO, July 07, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating Alphatec Holdings, Inc. (NASDAQ: ATEC) on behalf of investors who suffered losses and whether those losses may be recoverable under federal securities laws.
3 months ago · prnewswire.com
ATEC Investors Have Opportunity to Join Alphatec Holdings, Inc. Fraud Investigation with the Schall Law FirmLOS ANGELES, June 11, 2026 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Alphatec Holdings, Inc. ("Alphatec" or "the Company") (NASDAQ: ATEC) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
3 months ago · fool.com
Alphatec vs. Inspire Medical Systems: Which Healthcare Stock Is a Better Buy in 2026?Alphatec bets on integrated spine surgery tech, while Inspire leads in sleep apnea devices with robust profitability. How do their financials and risks stack up?
3 months ago · prnewswire.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alphatec Holdings, Inc. - ATECNEW YORK, June 11, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Alphatec Holdings, Inc. ("Alphatec" or the "Company") (NASDAQ: ATEC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
Analyst Summary
Add to Watchlist
Select watchlists to add or remove ATEC